missing translation for 'onlineSavingsMsg'
Learn More
Learn More
.jpg-650.jpg)
Novacyt Group Microgen Bioproducts™ SARS-CoV-2 IgG EIA
For the screening of patients previously infected, to either; confirm infection, monitor the course of disease, or to draw epidemiological conclusions. Includes all additional reagents required to perform each test.
Marca: Novacyt Group MBCOV2CE
Questo articolo non è restituibile.
Consulta la politica di reso
Descrizione
- The Microgen Bioproducts™ SARS-CoV-2 IgG EIA introduces a highly sensitive and specific assay for the qualitative detection of IgG antibodies based on the nucleocapsid protein, usually detected two weeks after initial infection
- The test is intended for the screening of patients previously infected, to either; confirm infection, monitor the course of disease, or to draw epidemiological conclusions
- Each kit contains 480 reactions (5 x 96 well plates) and includes all additional reagents required to perform each test –alongside positive/negative controls. Sample types include human serum and plasma
- Convenient 480 reaction format (5 x 96 well plates) including all plates and additional reagents to perform the assay
- Compliant with The Medicines and Healthcare Product Regulatory Agency Ministry (MHRA) TPP
- High Sensitivity and Specificity
- Less than 1 hour 30 minutes incubation time
- Functional with human plasma and serum samples
- No cross-reactivity with common viral pathogens
- Validated for manual application, however also suitable for high-throughput ELISA automation
- Vital in the process of monitoring COVID-19 antibodies
Specifica
| Standard ELISA calibration format - Pos/neg controls included with the kit | |
| 2°C to 8°C | |
| Yes | |
| Enzyme-linked immunosorbent assay; chromatography/colour change | |
| Human Plasma or Human Serum | |
| Antibody ELISA | |
| ELISA | |
| Positive control 1 x 3.5 mL, Negative control 1 x 3.5 mL, Wash buffer 2 x 12 5 mL, Sample buffer 2 x 125 mL, Conjugate 1 x 60 mL, Substrate solution 1 x 60 mL, Stop solution 1 x 60 mL | |
| 480 | |
| Foil pouches and plastic bottles | |
| 5 μL of human plasma or human serum | |
| 0.994 | |
| Antibodies/Nucleocapsid protein |
| CE IVD certified, DoC Documentation | |
| Both positive and negative controls | |
| SARS-CoV-2 IgG Antibodies (Nucleocapsid Protein) | |
| 96-well Plate | |
| 100% - > 14 days post PCR confirmation | |
| Chemical compositions are found in Safety Data Sheets | |
| Manual OR Automated ELISA Systems & Plate Reader for Interpretation | |
| Polypropylene Plates | |
| Antibodies | |
| 15/Pk. | |
| Human | |
| Sterile | |
| <1.5 hr. |